글로벌 백혈구채취 장비 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 백혈구채취 장비 시장

Data Bridge Market Research는 백혈구채취 장치 시장이 2021-2028년 예측 기간 동안 약 41.18%의 CAGR을 보일 것이라고 분석했습니다. 백혈병 및 혈액 관련 질환 의 유병률 증가, 의료 기기 와 관련된 연구 개발 능력 과 첨단 의료 기술 도입에 대한 집중 증가 , 노령 인구 증가율, 특히 개발 도상국의 의료 인프라 개발에 대한 지출 증가 는 백혈구채취 장치 시장 성장에 기인하는 주요 요인입니다. 따라서 2020년에 2,446만 달러였던 시장 가치는 2028년까지 3,654만 달러로 급증할 것입니다.

백혈병은 혈액 샘플에서 백혈구를 분리하는 의료 시술입니다. 이 시술은 혈액학적 악성 종양이 있는 환자의 백혈구 수를 줄이기 위해 시행됩니다. 따라서 백혈구채취 장치는 이 시술을 용이하게 하는 데 사용되는 의료 장치입니다.

임상 연구에서 백혈구팩에 대한 수요의 급증은 시장 성장을 촉진하는 주요 요인 중 하나입니다.  혈액 기증 과 관련된 활동 수의 증가 와 기술의 혁신 및 발전이 결합된 것은 또 다른 시장 성장 결정 요인입니다. 개인 간의 건강 인식 증가, 백혈구(WBC) 분리 프로세스에 대한 승인 증가, 의료 관광 증가는 수익성 있는 시장 성장 기회를 더욱 창출할 다른 중요한 요인입니다.

However, improper and unfavourable reimbursement scenario in the developing and underdeveloped economies will derail the market growth rate. Also, high costs of therapeutic leukapheresis and cellular therapies and stringent donor recruitment criteria will further pose challenges for the market. Dearth of skilled professionals in the backward economies and rising concerns related to blood transfusion will also hamper the market growth rate.

This leukapheresis devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on leukapheresis devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Leukapheresis Devices Market Scope and Market Size

The leukapheresis devices market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the leukapheresis devices market is segmented into apheresis devices, leukapheresis columns and cell separators and leukoreduction filters.
• Based on application, the leukapheresis devices market is segmented into research applications and therapeutic applications.

The end user segment of leukapheresis devices market is segmented into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies and hospitals and transfusion centers.

Leukapheresis Devices Market Country Level Analysis

The leukapheresis devices market is analysed and market size insights and trends are provided by country, type, application and end user as referenced above.

The countries covered in the leukapheresis devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the leukapheresis devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increasing funding for research and development activities and growing occurrence of lukaemia. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing number of private biotechnology companies and ever-rising geriatric population.

The country section of the leukapheresis devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The leukapheresis devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for leukapheresis devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the leukapheresis devices market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Leukapheresis Devices Market Share Analysis

The leukapheresis devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to leukapheresis devices market.

백혈구채취 장치 시장 보고서에 포함된 주요 업체는 Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, TERUMO BCT INC., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., The Intelligent Tissue Group Lonza, BioIVT, Lmb Technologie GmbH, Grifols, SA, Kaneka Medical Europe NV 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66364